Mickaël Aoun

1.9k total citations
18 papers, 348 citations indexed

About

Mickaël Aoun is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Mickaël Aoun has authored 18 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Infectious Diseases and 8 papers in Oncology. Recurrent topics in Mickaël Aoun's work include Antifungal resistance and susceptibility (8 papers), Fungal Infections and Studies (6 papers) and Neutropenia and Cancer Infections (5 papers). Mickaël Aoun is often cited by papers focused on Antifungal resistance and susceptibility (8 papers), Fungal Infections and Studies (6 papers) and Neutropenia and Cancer Infections (5 papers). Mickaël Aoun collaborates with scholars based in Belgium, United States and Israel. Mickaël Aoun's co-authors include Jean Klášterský, M Paesmans, Ahmad Awada, Athanassios Kolivras, Eric Van Wijngaerden, R Sergysels, Y. Valcke, Franky Buyle, Françoise Van Bambeke and Linos Vandekerckhove and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Transplantation.

In The Last Decade

Mickaël Aoun

18 papers receiving 341 citations

Peers

Mickaël Aoun
Evangelos Kostis Greece
Deborah Cotton United States
Goh Ohji Japan
M Solbiati Italy
Sonia Isabel Cuervo Colombia
Linda Graviss United States
Jeffrey Tarrand United States
Sanjay Biswas India
Josef Koestler Germany
B Peters United Kingdom
Evangelos Kostis Greece
Mickaël Aoun
Citations per year, relative to Mickaël Aoun Mickaël Aoun (= 1×) peers Evangelos Kostis

Countries citing papers authored by Mickaël Aoun

Since Specialization
Citations

This map shows the geographic impact of Mickaël Aoun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mickaël Aoun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mickaël Aoun more than expected).

Fields of papers citing papers by Mickaël Aoun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mickaël Aoun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mickaël Aoun. The network helps show where Mickaël Aoun may publish in the future.

Co-authorship network of co-authors of Mickaël Aoun

This figure shows the co-authorship network connecting the top 25 collaborators of Mickaël Aoun. A scholar is included among the top collaborators of Mickaël Aoun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mickaël Aoun. Mickaël Aoun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Pappas, Peter G., José A. Vázquez, Ilana Oren, et al.. (2023). Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia: results from a Phase 2 trial. Journal of Antimicrobial Chemotherapy. 78(10). 2471–2480. 37 indexed citations
2.
Pappas, Peter G., Bart Jan Kullberg, José A. Vázquez, et al.. (2020). 147. Clinical Safety and Efficacy of Novel Antifungal, Fosmanogepix, in the Treatment of Candidemia: Results from a Phase 2 Proof of Concept Trial. Open Forum Infectious Diseases. 7(Supplement_1). S203–S204. 16 indexed citations
3.
Bulpa, Pierre, Galia Rahav, Ilana Oren, et al.. (2020). 1157. Clinical Safety, Efficacy, and Pharmacokinetics of Fosmanogepix, a Novel First-in-class Antifungal, in Patients with Renal Insufficiency: Subset Analysis from a Phase 2 Candidemia Trial. Open Forum Infectious Diseases. 7(Supplement_1). S605–S605. 7 indexed citations
4.
Maertens, Johan, Dominik Selleslag, Werner Heinz, et al.. (2018). Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole. Mycoses. 61(11). 868–876. 8 indexed citations
5.
Cornely, Oliver A., Michael Robertson, Shariq Haider, et al.. (2017). Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease. Journal of Antimicrobial Chemotherapy. 72(12). 3501–3501. 9 indexed citations
6.
7.
8.
Debaugnies, France, Laurent Busson, Alina Ferster, et al.. (2014). Detection of Herpesviridae in Whole Blood by Multiplex PCR DNA-Based Microarray Analysis after Hematopoietic Stem Cell Transplantation. Journal of Clinical Microbiology. 52(7). 2552–2556. 10 indexed citations
9.
Aoun, Mickaël, Franky Buyle, Stéphane De Wit, et al.. (2012). The Sanford Guide to Antimicrobial Therapy: 22nd edition of the Belgian/Luxembourg version 2010-2011. 2 indexed citations
10.
Paesmans, Marianne, Jean Klášterský, Johan Maertens, et al.. (2010). Predicting febrile neutropenic patients at low risk using the MASCC score: does bacteremia matter?. Supportive Care in Cancer. 19(7). 1001–1008. 28 indexed citations
11.
Klášterský, Jean, Ahmad Awada, M Paesmans, & Mickaël Aoun. (2010). Febrile neutropenia: A critical review of the initial management. Critical Reviews in Oncology/Hematology. 78(3). 185–194. 37 indexed citations
12.
Aoun, Mickaël, Franky Buyle, Athanassios Kolivras, et al.. (2010). The Sanford Guide to Antimicrobial Therapy 2010-2011. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 92 indexed citations
13.
Ahmad, Imran, John Kwan, Younes Maaroufi, et al.. (2009). Preemptive Management of Epstein-Barr Virus Reactivation After Hematopoietic Stem-Cell Transplantation. Transplantation. 87(8). 1240–1245. 48 indexed citations
14.
Ahmad, Imran, et al.. (2008). An Aspergillus Myocardial Abscess Diagnosed by Echocardiography. Journal of the American Society of Echocardiography. 21(10). 1177.e3–1177.e5. 4 indexed citations
15.
Aoun, Mickaël. (2007). Empiric therapy for febrile neutropenia: what are the choices?. Expert Review of Anti-infective Therapy. 5(3). 507–515. 5 indexed citations
16.
17.
Georgala, Aspasia, Marc Vekemans, M. Husson, et al.. (2006). Zygomycosis in the immunocompromised patient: a case report.. PubMed. 77 Suppl 2. 5–9. 2 indexed citations
18.
Lazarus, Hillard M., et al.. (1999). Intravenous Penciclovir for Treatment of Herpes Simplex Infections in Immunocompromised Patients: Results of a Multicenter, Acyclovir-Controlled Trial. Antimicrobial Agents and Chemotherapy. 43(5). 1192–1197. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Evangelos Kostis Breakdown of academic impact, for papers by Deborah Cotton Breakdown of academic impact, for papers by Goh Ohji Breakdown of academic impact, for papers by M Solbiati Breakdown of academic impact, for papers by Sonia Isabel Cuervo Breakdown of academic impact, for papers by Linda Graviss Breakdown of academic impact, for papers by Jeffrey Tarrand Breakdown of academic impact, for papers by Sanjay Biswas Breakdown of academic impact, for papers by Josef Koestler Breakdown of academic impact, for papers by B Peters
Rankless by CCL
2026